- Home
- CYAB vs ISPC Comparison
CYAB vs ISPC Comparison
Compare CYAB & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CYAB | ISPC |
|---|---|---|
| Founded | 2017 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Precision Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2M | 3.8M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | CYAB | ISPC |
|---|---|---|
| Price | $0.30 | $2.01 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 187.7K | 44.5K |
| Earning Date | 04-09-2026 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 87.03 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,928,998.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.25 | $0.10 |
| 52 Week High | $2.99 | $6.77 |
Technical Indicators
Market Signals| Indicator | CYAB | ISPC |
|---|---|---|
| Relative Strength Index (RSI) | 38.98 | 39.02 |
| Support Level | N/A | $0.20 |
| Resistance Level | $0.50 | $4.49 |
| Average True Range (ATR) | 0.03 | 0.15 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 46.84 | 35.00 |
Price Performance
Historical ComparisonAbout CYAB Cyabra Inc. Common Stock
Cyabra Inc is an AI-powered SaaS company that detects and analyzes online disinformation. Its platform uses machine learning to monitor social media and news data in real time, identify fake accounts and harmful narratives, and assess content authenticity and sentiment.
About ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas, Europe, the Middle East, Africa, and the Asia Pacific, with the majority coming from the Americas. The Company has one reportable segment: biospecimens.